ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0356

The Role of Neutrophils in the Clinical Severity of Lupus Nephritis Patients with Concurrent Skin Disease

Lais Osmani, Sicong Shan, Zoe Chafouleas, Jason Pettus and Sladjana Skopelja-Gardner, Dartmouth Hitchcock Medical Center, Lebanon, NH

Meeting: ACR Convergence 2021

Keywords: Lupus nephritis, neutrophils, rash, skin

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 6, 2021

Title: SLE – Diagnosis, Manifestations, & Outcomes Poster I: Diagnosis (0323–0356)

Session Type: Poster Session A

Session Time: 8:30AM-10:30AM

Background/Purpose: Skin disease affects >80% of lupus patients and has been linked to lupus nephritis (LN) flares. We recently found that skin inflammation caused by UV light can trigger both local and systemic immune responses, in the blood and the kidney. This inflammation also led to kidney injury, associated with increased expression of renal inflammatory and injury markers and proteinuria. The observed renal injury was mediated by neutrophils, which migrated from the inflamed skin to the kidneys, localizing predominantly to the tubulointerstitial areas. These data prompted the hypothesis that presence of concurrent skin disease in lupus patients leads to worse nephritis mediated by neutrophils.

Methods: Kidney biopsies from 43 LN patients (2005-2020, IRB# 02000844) were retrieved from the Dartmouth Hitchcock Medical Center tissue bank and grouped into: i) LN with concurrent skin rash (malar, subacute, or discoid n =15) and ii) LN without skin rash (EMR review and/or skin biopsy, n=6) at the time of LN diagnosis (class IV). Patients with inconclusive or incomplete skin findings were excluded. The study included only female patients. Clinical and laboratory data (absolute neutrophil (ANC) and lymphocyte (ALC) counts, serum creatinine, estimated glomerular filtration rate (GFR), autoantibody titers, and complement levels) were collected by retrospective chart review. Histologic and immunofluorescence data were extracted from kidney biopsy reports. Student’s t-test was performed to detect statistically significant differences between patient groups.

Results: Presence of skin rash at the time of LN flare was indicative of more active disease, reflected by higher ANA and anti-dsDNA IgG titers, and low complement C3 and C4 levels. Of interest, LN patients with concurrent skin disease had higher absolute neutrophil counts (p < 0.05) and neutrophil-lymphocyte ratio (p< 0.01), but not lymphocyte absolute counts, compared to LN patients without a concurrent skin rash. High neutrophil counts in the presence of skin disease associated with lower glomerular filtration rate (GFR < 60; p< 0.01). This association was not seen in the absence of concurrent skin disease and rash alone did not predict GFR. Analysis of kidney immunofluorescence revealed that concurrent skin disease at the time of LN flare associated with greater IgA deposition. In particular, increased renal IgA levels associated with higher neutrophil but not lymphocyte counts (p < 0.01). This was specific to IgA as no associations with IgG or IgM deposition were detected.

Conclusion: Our study provides several novel findings that suggest neutrophils may be the pathogenic link between skin inflammation and lupus nephritis flares: i) higher neutrophil counts are found in the presence of a skin rash at the time of LN flare, ii) neutrophilia but not lymphocytosis in the presence of a skin rash associates with worse kidney function (low GFR), and iii) high neutrophil levels in the presence of skin rash associate with increased renal IgA deposition. The newly identified relationship between neutrophil levels and kidney IgA provides a novel model of IgA-driven activation of neutrophils leading to kidney injury initiated by skin inflammation.


Disclosures: L. Osmani, None; S. Shan, None; Z. Chafouleas, None; J. Pettus, None; S. Skopelja-Gardner, None.

To cite this abstract in AMA style:

Osmani L, Shan S, Chafouleas Z, Pettus J, Skopelja-Gardner S. The Role of Neutrophils in the Clinical Severity of Lupus Nephritis Patients with Concurrent Skin Disease [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/the-role-of-neutrophils-in-the-clinical-severity-of-lupus-nephritis-patients-with-concurrent-skin-disease/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-role-of-neutrophils-in-the-clinical-severity-of-lupus-nephritis-patients-with-concurrent-skin-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology